🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To further characterize the safety profile of Menactra vaccine and to ident...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00728260
Treatments Being Tested
The purpose of this trial is to describe antibody persistence and response ...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01239043
The aim of this study is to generate local data on the safety of Menactra® ...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02699840
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
The primary objective of this study is to evaluate the safety of adjuvanted...
Status
Completed
Location
Center for Vaccine Development
Start Date
2016-08-01
Trial ID
NCT02810340
Treatments Being Tested
This study is designed to assess the safety and immunogenicity of a single ...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01519713
Treatments Being Tested
Primary Objective: To demonstrate the non-inferiority of the antibody resp...
Status
Completed
Location
Investigational Site Number 3920001
Start Date
2020-05-22
Trial ID
NCT04368429
This study was designed to simulate meningococcal challenge by vaccination ...
Status
Completed
Location
Multiple Locations
Start Date
2003-03
Trial ID
NCT00772070
The primary objective of this study is to demonstrate the non-inferiority o...
Status
Completed
Location
Alabama Clinical Therapeutics Site Number : 8400036
Start Date
2018-10-04
Trial ID
NCT03691610
Treatments Being Tested
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested